Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes.
Inhibition of PD1-PDL1 signaling in NOD mice accelerates onset of type 1 diabetes implicating this pathway in suppressing the emergence of pancreatic beta cell reactive T-cells. However, the molecular mechanism by which PD1 signaling protects from type 1 diabetes is not clear. We hypothesized that d...
Main Authors: | Nora M Kochupurakkal, Annie J Kruger, Sudipta Tripathi, Bing Zhu, La Tonya Adams, Daniel B Rainbow, Aldo Rossini, Dale L Greiner, Mohamed H Sayegh, Linda S Wicker, Indira Guleria |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3938467?pdf=render |
Similar Items
-
Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus
by: Sudipta Tripathi, et al.
Published: (2015-02-01) -
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells.
by: Sudipta Tripathi, et al.
Published: (2015-01-01) -
Viral Infection: A Potent Barrier to Transplantation Tolerance
by: David M. Miller, et al.
Published: (2008-01-01) -
B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade.
by: Katherine J Nicholas, et al.
Published: (2013-01-01) -
RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
by: Elizabeth Ahern, et al.
Published: (2018-06-01)